TRPC7-AS1: A Potential Drug Target and Biomarker (G100874024)

Target Name: TRPC7-AS1

NCBI ID: G100874024

Other Name(s): TRPC7 antisense RNA 1

TRPC7-AS1: A Potential Drug Target and Biomarker

TRPC7 (Transient receptor potential cation channel subfamily 7) is a family of G protein-coupled receptors that play a crucial role in cellular signaling. The TRPC7 gene has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric disorders. In this article, we will discuss TRPC7-AS1, a TRPC7 receptor that has been targeted by drug developers and researchers as a potential drug target and biomarker.

TRPC7-AS1: Structure and Function

TRPC7-AS1 is a 7-transmembrane protein that consists of an extracellular domain, a transmembrane domain, an intracellular domain, and a unique N-terminal region called the AS1 region. The TRPC7-AS1 receptor has a pore-like structure that allows it to interact with various signaling molecules, including small molecules, ions, and neurotransmitters.

The TRPC7-AS1 receptor is composed of four subunits, each composed of a catalytic 伪尾 subunit and a non-catalytic 纬未 subunit. The 伪尾 subunit consists of a nucleotide-binding oligomerization domain (NBD), a zinc ion-binding domain (ZBD), and a carboxylic acid-binding domain (CBD). The NBD and ZBD domains play crucial roles in the receptor's signaling pathway.

TRPC7-AS1 Receptor Signaling

TRPC7-AS1 is a potent modulator of various physiological processes, including pain perception, neurotransmission, and cell signaling. The TRPC7-AS1 receptor has been shown to play a crucial role in pain perception and neurotransmission.

TRPC7-AS1 has been shown to interact with various neurotransmitters, including opioids, GABA, and glutamate. Studies have shown that activation of the TRPC7-AS1 receptor can lead to the release of these neurotransmitters, which can then modulate various cellular processes, including pain perception, neurotransmission, and gene expression.

TRPC7-AS1 has also been shown to play a role in cell signaling. The TRPC7-AS1 receptor has been shown to interact with various signaling molecules, including T-cell signaling, stem cell proliferation, and neuroprotection.

TRPC7-AS1 as a Potential Drug Target

TRPC7-AS1 has been identified as a potential drug target due to its involvement in various diseases, including cancer, neurodegenerative disorders, and psychiatric disorders.

TRPC7-AS1 has been shown to be overexpressed or underexpressed in various diseases, including cancer, neurodegenerative disorders, and psychiatric disorders. Overexpression of the TRPC7-AS1 receptor has been shown to contribute to the development and progression of these diseases.

TRPC7-AS1 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric disorders. The levels of TRPC7-AS1 have been shown to be altered in the brains of individuals with various psychiatric disorders, including depression, anxiety, and schizophrenia.

TRPC7-AS1 as a Potential Biomarker

TRPC7-AS1 has been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric disorders. The levels of TRPC7-AS1 have been shown to be altered in the brains of individuals with

Protein Name: TRPC7 Antisense RNA 1

More Common Targets